{"denoms":[{"counts":[{"groupId":"BG000","value":"34"}],"units":"Participants"}],"groups":[{"description":"Abraxane 220 mg/m\\^2 intravenously on Day 1 of 21 day cycle.","id":"BG000","title":"Abraxane"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"34","upperLimit":"77","value":"59"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"20"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"34"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}],"title":"Small Bowel Adenocarcinoma (SBA)"},{"measurements":[{"groupId":"BG000","value":"21"}],"title":"CIMP-high Colorectal Cancer (CRC)"}]}],"description":"Histologically or cytologically confirmed colorectal adenocarcinoma (CpG island methylator phenotype (CIMP-high)) or small bowel adenocarcinoma","paramType":"COUNT_OF_PARTICIPANTS","title":"Colorectal Cancer Diagnosis","unitOfMeasure":"Participants"}]}